白血病·淋巴瘤
白血病·淋巴瘤
백혈병·림파류
Journal of Leukemia & Lymphoma
2015年
10期
595-597
,共3页
许肖冰%魏旭东%尹青松%汪萍%艾昊%米瑞华%陈琳
許肖冰%魏旭東%尹青鬆%汪萍%艾昊%米瑞華%陳琳
허초빙%위욱동%윤청송%왕평%애호%미서화%진림
淋巴瘤,T细胞%沙利度胺%干扰素%复发难治
淋巴瘤,T細胞%沙利度胺%榦擾素%複髮難治
림파류,T세포%사리도알%간우소%복발난치
Lymphoma,T-cell%Thalidomide%Interferon%Relapsed and refractory
目的 探讨沙利度胺联合干扰素治疗复发难治T细胞淋巴瘤(TCL)的效果及患者不良反应.方法 观察使用沙利度胺联合干扰素治疗2例复发难治TCL患者的效果及不良反应,并复习相关文献.结果 2例患者均达部分缓解(PR),无明显不良反应.结论 沙利度胺联合干扰素治疗复发难治TCL有一定的疗效,可作为治疗复发难治TCL的一种新的选择.
目的 探討沙利度胺聯閤榦擾素治療複髮難治T細胞淋巴瘤(TCL)的效果及患者不良反應.方法 觀察使用沙利度胺聯閤榦擾素治療2例複髮難治TCL患者的效果及不良反應,併複習相關文獻.結果 2例患者均達部分緩解(PR),無明顯不良反應.結論 沙利度胺聯閤榦擾素治療複髮難治TCL有一定的療效,可作為治療複髮難治TCL的一種新的選擇.
목적 탐토사리도알연합간우소치료복발난치T세포림파류(TCL)적효과급환자불량반응.방법 관찰사용사리도알연합간우소치료2례복발난치TCL환자적효과급불량반응,병복습상관문헌.결과 2례환자균체부분완해(PR),무명현불량반응.결론 사리도알연합간우소치료복발난치TCL유일정적료효,가작위치료복발난치TCL적일충신적선택.
Objective To observe the effectiveness and side-effect of two cases of relapsed and refractory T-cell lymphoma (TCL) treated with thalidomide and interferon.Methods Two cases of relapsed and refractory TCL was treated with thalidomide and interferon, the efficacy and side-effect were observed, and the relevant literature was reviewed.Results The patients achieved partially remission after being treated with thalidomide and interferon.Conclusion Thalidomide in combination with interferon can be used as a second line therapy for relapsed and refractory TCL.
